Speaker profile
Ruth Gimeno
Group Vice President of Diabetes, Obesity and Cardiometabolic Research at Eli Lilly
Listed for 2 events in our database
About
Ruth Gimeno, Ph.D., is Group Vice President at Eli Lilly and Company, leading cardiometabolic research and early clinical development across diabetes, obesity, cardiorenal diseases, and women's health. Under her leadership, Lilly has advanced a broad portfolio spanning obesity — with molecules such as tirzepatide, orforglipron, retatrutide, and eloralintide — as well as programs in diabetes and cardiovascular disease.
Speaking appearances
- 2026-10-21
DOC 2026: Longevity Science & Medical AI
Sonoma, United States · speaker
Panel: Rise of the Peptides: GLP-1s, BPC 157, WTF?
- 2026-10-01
ARDD 2026
Boston, United States · panelist
Panel: Diseases as a Pathway to Longevity Therapeutics: Which age-related disease resembles aging most closely?